Analyst Research: Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

13.70USD
30 Jul 2014
Price Change (% chg)

$0.05 (+0.37%)
Prev Close
$13.65
Open
$13.89
Day's High
$14.25
Day's Low
$13.47
Volume
443,420
Avg. Vol
637,897
52-wk High
$38.82
52-wk Low
$10.77

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
CLDX: Due Diligence Review: Forensic Earnings and Valuation 30 Jul 2014 New Constructs, LLC 9 25.00
Thomson Reuters Stock Report - CELLDEX THERAPEUTICS, INCORPORATION (CLDX-O) 30 Jul 2014 Thomson Reuters Stock Report 11 25.00
Will Celldex Therapeutics, Inc. Continue its Slide? 29 Jul 2014 Sadif Analytics (Premium) 12 25.00
Wright Investors Service Comprehensive Report for Celldex Therapeutics, Incorporation 28 Jul 2014 Wright Reports 56 75.00
"The Economy Matters" Report for CLDX: the economy's impact on CLDX's price and risk, featuring the powerful Economic Climate Rating 28 Jul 2014 MacroRisk Analytics/EconomicInvestor 7 25.00
ValuEngine Rating and Forecast Report for CLDX 27 Jul 2014 ValuEngine, Inc. 11 25.00
Celldex Therapeutics 26 Jul 2014 S&P Capital IQ Quantitative Report 10 115.00
CELLDEX THERAPEUTICS INC (CLDX) - REPORT FOR ACTIVE TRADERS 25 Jul 2014 Pechala's Reports 1 25.00
CELLDEX THERAPT (CLDX) Zacks Company Snapshot 23 Jul 2014 Zacks Investment Research Inc. 1 12.00
TheStreet.com Ratings Stock Report For: CELLDEX THERAPEUTICS INC (CLDX) 20 Jul 2014 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Larry Ellberger

66 2009 Independent Chairman of the Board

Anthony Marucci

52 2008 President, Chief Executive Officer, Director

Avery Catlin

66 2001 Chief Financial Officer, Senior Vice President, Secretary

Tibor Keler

55 2008 Senior Vice President, Chief Scientific Officer

Thomas Davis

50 2008 Senior Vice President, Chief Medical Officer
Search Stocks